Multifaceted Intervention by the Hsp90 Inhibitor Ganetespib (STA-9090) in Cancer Cells with Activated JAK/STAT Signaling
There is accumulating evidence that dysregulated JAK signaling occurs in a wide variety of cancer types. In particular, mutations in JAK2 can result in the constitutive activation of STAT transcription factors and lead to oncogenic growth. JAK kinases are established Hsp90 client proteins and here w...
保存先:
主要な著者: | , , , , , , , , , , , |
---|---|
フォーマット: | Artigo |
言語: | 英語 |
出版事項: |
2011
|
オンライン・アクセス: | https://doi.org/10.1371/journal.pone.0018552 https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0018552&type=printable |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|